Get the Stockscreener App
20.77
0.95%
-0.20
After Hours:
20.98
0.21
+1.01%
Innoviva Inc stock is traded at $20.77, with a volume of 799.10K.
It is down -0.95% in the last 24 hours and down -6.90% over the past month.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
See More
Previous Close:
$20.97
Open:
$20.97
24h Volume:
799.10K
Relative Volume:
0.99
Market Cap:
$1.53B
Revenue:
$434.49M
Net Income/Loss:
$504.34M
P/E Ratio:
3.4537
EPS:
6.0138
Net Cash Flow:
$181.97M
1W Performance:
-2.49%
1M Performance:
-6.90%
6M Performance:
-1.10%
1Y Performance:
+11.49%
1-Day Range:
$20.60
$21.16
1-Week Range:
$20.60
$21.95
52-Week Range:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.77 | 1.57B | 434.49M | 504.34M | 181.97M | 6.0138 |
VRTX
Vertex Pharmaceuticals Inc
|
470.72 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
759.24 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
830.79 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
182.45 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
313.77 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Initiated | BTIG Research | Buy |
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Innoviva earnings up next: Can LYNX platform pivot pay off? By Investing.com - Investing.com Australia
Innoviva (INVA): Affordable Growth Stock at a Reasonable Valuation - ChartMill
Innoviva Inc (INVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Innoviva Inc (INVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Innoviva Inc (INVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thai FDA approves Dr Reddy’s gonorrhoea antibiotic - ET Pharma
Innoviva Inc (INVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Innoviva Market Sentiment - Benzinga España
Innoviva Inc (INVA) Balance Sheet - TradingKey
Innoviva, Inc. Revenue Breakdown – MUN:HVE - TradingView
INVA|Innoviva Inc|Price:21.440|Chg%:+0.240 - TradingKey
Innoviva Inc (INVA) Cash Flow - TradingKey
Innoviva, Inc. Revenue Breakdown – DUS:HVE - TradingView
Innoviva Inc (INVA) Income Statement - TradingKey
Innoviva Inc (INVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 66.82% Upside in the Healthcare Sector - DirectorsTalk Interviews
How Innoviva Inc. (INVA) Affects Rotational Strategy Timing - Stock Traders Daily
Innoviva (INVA) Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesEPS Revision Trend - dars.gov.et
Innoviva to Participate in Upcoming Investor Conferences - AOL.com
Innoviva (INVA) Leaves Russell Indexes, Is The Stock Still Cheap? - simplywall.st
Innoviva Inc (NASDAQ:INVA): A Decent Value Play with Strong Fundamentals - ChartMill
Enterprise value to EBITDA forward of Innoviva, Inc. – SWB:HVE - TradingView
Price to sales forward of Innoviva, Inc. – SWB:HVE - TradingView
Innoviva Inc. (INVA) Sees Modest Uptick, Testing Resistance Near $23.43Safe Entry Stocks - dars.gov.et
INVAInnoviva Inc Latest SEC Filings - Finviz
Is Innoviva (INVA) Trading Index Membership for a Deeper Bet on Nortiva Bio’s LYNX Platform? - simplywall.st
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now? - Insider Monkey
5 Cheap Small Cap Stocks to Buy Now - Insider Monkey
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal? - Sahm
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2000 Growth-Defensive Index - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
INVA Forecast — Price Target — Prediction for 2027 - TradingView
How Investors Are Reacting To Innoviva (INVA) Expanding Drug Delivery Tech And XACDURO Global Partnership - Sahm
Enterprise value to EBIT forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
INNOVIVA INC (NASDAQ:INVA): A Strong Growth Stock Poised for a Technical Breakout - ChartMill
Price to earnings forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
(INVA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Price to book forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
Enterprise value to revenue forward of Innoviva, Inc. – GETTEX:HVE - TradingView
Innoviva, Inc. Actuals & Estimates (NASDAQ:INVA) - TradingView
Innoviva, Inc. Actuals & Estimates (DUS:HVE) - TradingView
HVE Forecast — Price Target — Prediction for 2027 - TradingView
Innoviva Inc (INVA) Institutional Confidence - TradingKey
Has Innoviva Successfully Pivoted Beyond its Royalty Roots - Kavout | AI
Price to sales forward of Innoviva, Inc. – GETTEX:HVE - TradingView
Innoviva, Inc. Actuals & Estimates (SWB:HVE) - TradingView
Innoviva, Inc. Actuals & Estimates (LS:A2AC9U) - TradingView
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):